Letter: elevated aspartate aminotransferase and aspartate aminotransferase to alanine aminotransferase ratio predicts poor survival in hepatocellular carcinoma after resection
- PMID: 33205878
- DOI: 10.1111/apt.16124
Letter: elevated aspartate aminotransferase and aspartate aminotransferase to alanine aminotransferase ratio predicts poor survival in hepatocellular carcinoma after resection
Comment in
-
Letter: elevated aspartate aminotransferase and aspartate aminotransferase to alanine aminotransferase ratio predicts poor survival in hepatocellular carcinoma after resection-Authors' reply.Aliment Pharmacol Ther. 2020 Dec;52(11-12):1764. doi: 10.1111/apt.16138. Aliment Pharmacol Ther. 2020. PMID: 33205870 No abstract available.
Comment on
-
East Asia expert opinion on treatment initiation for chronic hepatitis B.Aliment Pharmacol Ther. 2020 Nov;52(10):1540-1550. doi: 10.1111/apt.16097. Epub 2020 Sep 20. Aliment Pharmacol Ther. 2020. PMID: 32951256 Review.
References
REFERENCES
-
- Kao JH, Hu TH, Jia J, et al. East Asia expert opinion on treatment initiation for chronic hepatitis B. Aliment Pharmacol Ther. 2020;52:1540-1550.
-
- European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370-398.
-
- Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology. 1988;95:734-739.
-
- Chen C-H, Su W-W, Yang S-S, et al. Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: analysis of 11,312 patients in Taiwan. J Gastroenterol Hepatol. 2006;21(10):1561-1566.
-
- von Felden J, Wege H, Schulze K. Elevated aspartate aminotransferase to alanine aminotransferase ratio predicts poor outcome in hepatocellular carcinoma. Hepatol Commun. 2020;4:1382-1383.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical